In February, during AMD Awareness Month, Research to Prevent Blindness held a virtual event, "RPB Lunch & Learn: Eye on Geographic Atrophy and Dry AMD," designed to educate RPB's community on the pathology and features of GA and dry age-related macular degeneration (AMD), as well as explore cutting-edge research directions that are shedding light on early diagnosis and treatment options. The event, which was sponsored by Apellis Pharmaceuticals, featured:
We are pleased to present a recording of this event:
March 17, 2022
Award recipients to use the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) clinical database to improve care for all patients.
Research to Prevent Blindness and Castle Biosciences are partnering to provide new opportunities for medical students to pursue ocular cancer research.
Research to Prevent Blindness and Aerie Pharmaceuticals are partnering to provide grant opportunities to support novel research in glaucoma.
RPB and the AOCOO-HNS Foundation are launching a multi-year partnership to provide funding to increase research opportunities in vision science for students of osteopathic medicine.
This ground-breaking research accomplishment will open new doors for research on neurodegenerative diseases like AMD.
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, ocular cancer, amblyopia, low vision, and many more.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |